25 XP   0   0   10

Dali Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Dali Pharmaceutical Co Ltd together

PenkeI guess you are interested in Dali Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Dali Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Dali Pharmaceutical Co Ltd

I send you an email if I find something interesting about Dali Pharmaceutical Co Ltd.

Quick analysis of Dali Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Dali Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.01
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥1.83
Expected worth in 1 year
¥1.50
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
¥-0.28
Return On Investment
-3.5%

For what price can you sell your share?

Current Price per Share
¥8.10
Expected price per share
¥5.24 - ¥18.47
How sure are you?
50%

1. Valuation of Dali Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥8.10

Intrinsic Value Per Share

¥-1.91 - ¥0.62

Total Value Per Share

¥-0.08 - ¥2.45

2. Growth of Dali Pharmaceutical Co Ltd (5 min.)




Is Dali Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$55.3m$57.8m-$2.4m-4.4%

How much money is Dali Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$2.4m-$5.7m$3.3m136.6%
Net Profit Margin-13.4%-24.4%--

How much money comes from the company's main activities?

3. Financial Health of Dali Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Dali Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Dali Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Dali Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Dali Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Dali Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Dali Pharmaceutical Co Ltd is ¥8.1. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Dali Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Dali Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥1.83. Based on the TTM, the Book Value Change Per Share is ¥-0.08 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.24 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Dali Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps-0.01-0.1%-0.01-0.1%-0.03-0.3%0.000.0%0.010.1%
Usd Book Value Change Per Share-0.01-0.1%-0.01-0.1%-0.03-0.4%-0.01-0.1%0.010.2%
Usd Dividend Per Share0.000.0%0.000.0%0.010.1%0.000.1%0.030.3%
Usd Total Gains Per Share-0.01-0.1%-0.01-0.1%-0.03-0.3%0.000.0%0.040.5%
Usd Price Per Share1.80-1.80-1.22-1.25-0.81-
Price to Earnings Ratio-162.09--162.09--46.36-121.22-67.03-
Price-to-Total Gains Ratio-185.21--185.21--48.07-98.20-83.38-
Price to Book Ratio7.15-7.15-4.64-4.56-2.90-
Price-to-Total Gains Ratio-185.21--185.21--48.07-98.20-83.38-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.1178
Number of shares894
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.01-0.01
Usd Total Gains Per Share-0.010.00
Gains per Quarter (894 shares)-8.70-3.06
Gains per Year (894 shares)-34.80-12.24
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
15-40-4516-28-22
210-80-8031-56-34
315-119-11547-84-46
420-159-15063-112-58
525-199-18579-140-70
630-239-22094-168-82
735-278-255110-196-94
840-318-290126-224-106
945-358-325142-252-118
1050-398-360157-280-130

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%6.02.02.060.0%6.02.03.054.5%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%6.04.00.060.0%7.04.00.063.6%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%11.00.00.0100.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%8.02.00.080.0%9.02.00.081.8%

Fundamentals of Dali Pharmaceutical Co Ltd

About Dali Pharmaceutical Co Ltd

Dali Pharmaceuticalco.,Ltd researches, develops, produces, and sells pharmaceutical products in China. It develops Chinese and Western medicine injection. The company's products include xingnaojing, shenmai, and astragalus injections, as well as citicoline injections. It also has patents, including invention patents and utility models. The company was founded in 1996 and is headquartered in Dali, China.

Fundamental data was last updated by Penke on 2024-04-18 15:09:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Dali Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Dali Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Dali Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -13.4% means that ¥-0.13 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Dali Pharmaceutical Co Ltd:

  • The MRQ is -13.4%. The company is making a huge loss. -2
  • The TTM is -13.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-13.4%TTM-13.4%0.0%
TTM-13.4%YOY-24.4%+11.1%
TTM-13.4%5Y-5.8%-7.6%
5Y-5.8%10Y1.0%-6.8%
1.1.2. Return on Assets

Shows how efficient Dali Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Dali Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -3.5% Return on Assets means that Dali Pharmaceutical Co Ltd generated ¥-0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Dali Pharmaceutical Co Ltd:

  • The MRQ is -3.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.5%TTM-3.5%0.0%
TTM-3.5%YOY-7.6%+4.1%
TTM-3.5%5Y-1.3%-2.2%
5Y-1.3%10Y2.2%-3.5%
1.1.3. Return on Equity

Shows how efficient Dali Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Dali Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -4.4% Return on Equity means Dali Pharmaceutical Co Ltd generated ¥-0.04 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Dali Pharmaceutical Co Ltd:

  • The MRQ is -4.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -4.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.4%TTM-4.4%0.0%
TTM-4.4%YOY-10.0%+5.6%
TTM-4.4%5Y-1.7%-2.7%
5Y-1.7%10Y3.0%-4.7%

1.2. Operating Efficiency of Dali Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Dali Pharmaceutical Co Ltd is operating .

  • Measures how much profit Dali Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Dali Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -16.9% means the company generated ¥-0.17  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Dali Pharmaceutical Co Ltd:

  • The MRQ is -16.9%. The company is operating very inefficient. -2
  • The TTM is -16.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-16.9%TTM-16.9%0.0%
TTM-16.9%YOY-7.7%-9.2%
TTM-16.9%5Y-4.5%-12.4%
5Y-4.5%10Y2.8%-7.3%
1.2.2. Operating Ratio

Measures how efficient Dali Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.61 means that the operating costs are ¥1.61 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Dali Pharmaceutical Co Ltd:

  • The MRQ is 1.606. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.606. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.606TTM1.6060.000
TTM1.606YOY1.345+0.261
TTM1.6065Y1.322+0.283
5Y1.32210Y1.053+0.269

1.3. Liquidity of Dali Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Dali Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.97 means the company has ¥3.97 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Dali Pharmaceutical Co Ltd:

  • The MRQ is 3.969. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.969. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.969TTM3.9690.000
TTM3.969YOY3.835+0.134
TTM3.9695Y3.907+0.062
5Y3.90710Y2.422+1.485
1.3.2. Quick Ratio

Measures if Dali Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Dali Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 3.04 means the company can pay off ¥3.04 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Dali Pharmaceutical Co Ltd:

  • The MRQ is 3.045. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.045. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.045TTM3.0450.000
TTM3.045YOY1.546+1.499
TTM3.0455Y2.390+0.654
5Y2.39010Y1.497+0.894

1.4. Solvency of Dali Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Dali Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Dali Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.20 means that Dali Pharmaceutical Co Ltd assets are financed with 20.3% credit (debt) and the remaining percentage (100% - 20.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Dali Pharmaceutical Co Ltd:

  • The MRQ is 0.203. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.203. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.203TTM0.2030.000
TTM0.203YOY0.237-0.033
TTM0.2035Y0.203+0.001
5Y0.20310Y0.236-0.033
1.4.2. Debt to Equity Ratio

Measures if Dali Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Dali Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 25.5% means that company has ¥0.26 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Dali Pharmaceutical Co Ltd:

  • The MRQ is 0.255. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.255. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.255TTM0.2550.000
TTM0.255YOY0.310-0.055
TTM0.2555Y0.2550.000
5Y0.25510Y0.312-0.057

2. Market Valuation of Dali Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Dali Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Dali Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -162.09 means the investor is paying ¥-162.09 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Dali Pharmaceutical Co Ltd:

  • The EOD is -100.532. Based on the earnings, the company is expensive. -2
  • The MRQ is -162.092. Based on the earnings, the company is expensive. -2
  • The TTM is -162.092. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-100.532MRQ-162.092+61.560
MRQ-162.092TTM-162.0920.000
TTM-162.092YOY-46.362-115.730
TTM-162.0925Y121.218-283.310
5Y121.21810Y67.034+54.184
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Dali Pharmaceutical Co Ltd:

  • The EOD is -53.599. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -86.420. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -86.420. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-53.599MRQ-86.420+32.821
MRQ-86.420TTM-86.4200.000
TTM-86.420YOY-141.929+55.509
TTM-86.4205Y-79.198-7.221
5Y-79.19810Y-64.441-14.757
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Dali Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Dali Pharmaceutical Co Ltd:

  • The EOD is 4.436. Based on the equity, the company is fair priced.
  • The MRQ is 7.153. Based on the equity, the company is overpriced. -1
  • The TTM is 7.153. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD4.436MRQ7.153-2.716
MRQ7.153TTM7.1530.000
TTM7.153YOY4.637+2.516
TTM7.1535Y4.561+2.591
5Y4.56110Y2.897+1.664
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Dali Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.081-0.0810%-0.237+194%-0.057-30%0.107-175%
Book Value Per Share--1.8261.8260%1.906-4%2.023-10%1.669+9%
Current Ratio--3.9693.9690%3.835+3%3.907+2%2.422+64%
Debt To Asset Ratio--0.2030.2030%0.237-14%0.203+0%0.236-14%
Debt To Equity Ratio--0.2550.2550%0.310-18%0.2550%0.312-18%
Dividend Per Share--0.0100.0100%0.053-81%0.032-68%0.203-95%
Eps---0.081-0.0810%-0.191+137%-0.029-64%0.062-229%
Free Cash Flow Per Share---0.151-0.1510%-0.062-59%-0.016-90%0.141-207%
Free Cash Flow To Equity Per Share---0.151-0.1510%0.011-1447%-0.047-69%0.175-186%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.700+43%
Intrinsic Value_10Y_max--0.624--------
Intrinsic Value_10Y_min---1.907--------
Intrinsic Value_1Y_max--0.124--------
Intrinsic Value_1Y_min---0.137--------
Intrinsic Value_3Y_max--0.326--------
Intrinsic Value_3Y_min---0.461--------
Intrinsic Value_5Y_max--0.471--------
Intrinsic Value_5Y_min---0.836--------
Market Cap1779570000.000-61%2869282000.0002869282000.0000%1942148000.000+48%1992718546.000+44%1281960485.000+124%
Net Profit Margin---0.134-0.1340%-0.244+83%-0.058-57%0.010-1464%
Operating Margin---0.169-0.1690%-0.077-54%-0.045-73%0.028-702%
Operating Ratio--1.6061.6060%1.345+19%1.322+21%1.053+53%
Pb Ratio4.436-61%7.1537.1530%4.637+54%4.561+57%2.897+147%
Pe Ratio-100.532+38%-162.092-162.0920%-46.362-71%121.218-234%67.034-342%
Price Per Share8.100-61%13.06013.0600%8.840+48%9.070+44%5.835+124%
Price To Free Cash Flow Ratio-53.599+38%-86.420-86.4200%-141.929+64%-79.198-8%-64.441-25%
Price To Total Gains Ratio-114.871+38%-185.211-185.2110%-48.067-74%98.201-289%83.375-322%
Quick Ratio--3.0453.0450%1.546+97%2.390+27%1.497+103%
Return On Assets---0.035-0.0350%-0.076+117%-0.013-64%0.022-258%
Return On Equity---0.044-0.0440%-0.100+127%-0.017-61%0.030-245%
Total Gains Per Share---0.071-0.0710%-0.184+161%-0.025-65%0.310-123%
Usd Book Value--55359577.32755359577.3270%57802390.847-4%61344296.327-10%50609179.239+9%
Usd Book Value Change Per Share---0.011-0.0110%-0.033+194%-0.008-30%0.015-175%
Usd Book Value Per Share--0.2520.2520%0.263-4%0.279-10%0.230+9%
Usd Dividend Per Share--0.0010.0010%0.007-81%0.004-68%0.028-95%
Usd Eps---0.011-0.0110%-0.026+137%-0.004-64%0.009-229%
Usd Free Cash Flow---4581835.857-4581835.8570%-1888386.829-59%-471542.273-90%4262517.177-207%
Usd Free Cash Flow Per Share---0.021-0.0210%-0.009-59%-0.002-90%0.019-207%
Usd Free Cash Flow To Equity Per Share---0.021-0.0210%0.002-1447%-0.007-69%0.024-186%
Usd Market Cap245580660.000-61%395960916.000395960916.0000%268016424.000+48%274995159.348+44%176910546.930+124%
Usd Price Per Share1.118-61%1.8021.8020%1.220+48%1.252+44%0.805+124%
Usd Profit---2442813.521-2442813.5210%-5780897.332+137%-887463.747-64%1027598.750-338%
Usd Revenue--18263476.64618263476.6460%23666073.302-23%33485111.822-45%36776800.298-50%
Usd Total Gains Per Share---0.010-0.0100%-0.025+161%-0.003-65%0.043-123%
 EOD+3 -5MRQTTM+0 -0YOY+18 -175Y+8 -2710Y+13 -23

3.2. Fundamental Score

Let's check the fundamental score of Dali Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-100.532
Price to Book Ratio (EOD)Between0-14.436
Net Profit Margin (MRQ)Greater than0-0.134
Operating Margin (MRQ)Greater than0-0.169
Quick Ratio (MRQ)Greater than13.045
Current Ratio (MRQ)Greater than13.969
Debt to Asset Ratio (MRQ)Less than10.203
Debt to Equity Ratio (MRQ)Less than10.255
Return on Equity (MRQ)Greater than0.15-0.044
Return on Assets (MRQ)Greater than0.05-0.035
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Dali Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.551
Ma 20Greater thanMa 509.553
Ma 50Greater thanMa 1009.223
Ma 100Greater thanMa 20010.219
OpenGreater thanClose7.880
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets503,486
Total Liabilities102,330
Total Stockholder Equity401,156
 As reported
Total Liabilities 102,330
Total Stockholder Equity+ 401,156
Total Assets = 503,486

Assets

Total Assets503,486
Total Current Assets308,732
Long-term Assets194,754
Total Current Assets
Cash And Cash Equivalents 43,839
Short-term Investments 229,233
Net Receivables 7,577
Inventory 27,021
Other Current Assets 598
Total Current Assets  (as reported)308,732
Total Current Assets  (calculated)308,268
+/- 464
Long-term Assets
Property Plant Equipment 86,584
Intangible Assets 35,950
Long-term Assets Other 1,568
Long-term Assets  (as reported)194,754
Long-term Assets  (calculated)124,102
+/- 70,652

Liabilities & Shareholders' Equity

Total Current Liabilities77,779
Long-term Liabilities24,551
Total Stockholder Equity401,156
Total Current Liabilities
Accounts payable 9,100
Other Current Liabilities 19,675
Total Current Liabilities  (as reported)77,779
Total Current Liabilities  (calculated)28,775
+/- 49,004
Long-term Liabilities
Long term Debt 23,781
Long-term Liabilities  (as reported)24,551
Long-term Liabilities  (calculated)23,781
+/- 769
Total Stockholder Equity
Retained Earnings 30,988
Total Stockholder Equity (as reported)401,156
Total Stockholder Equity (calculated)30,988
+/- 370,168
Other
Capital Stock219,700
Common Stock Shares Outstanding 219,700
Net Invested Capital 424,938
Net Working Capital 230,953
Property Plant and Equipment Gross 253,463



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
> Total Assets 
298,580
351,620
358,676
351,567
291,453
612,763
594,510
561,329
578,711
548,746
503,486
503,486548,746578,711561,329594,510612,763291,453351,567358,676351,620298,580
   > Total Current Assets 
0
0
0
0
138,455
437,340
430,106
390,127
388,459
348,545
308,732
308,732348,545388,459390,127430,106437,340138,4550000
       Cash And Cash Equivalents 
80,485
76,867
28,548
0
68,475
69,754
101,698
82,633
63,333
180,659
43,839
43,839180,65963,33382,633101,69869,75468,475028,54876,86780,485
       Short-term Investments 
19,000
10,000
71,581
0
13,170
234,300
225,188
225,230
240,748
132,444
229,233
229,233132,444240,748225,230225,188234,30013,170071,58110,00019,000
       Net Receivables 
5,547
8,213
11,292
1,351
1,204
16,430
35,076
19,730
9,709
8,046
7,577
7,5778,0469,70919,73035,07616,4301,2041,35111,2928,2135,547
       Other Current Assets 
1,027
8,685
183
364
597
836
525
3,649
1,705
40
598
598401,7053,6495258365973641838,6851,027
   > Long-term Assets 
0
0
0
0
152,997
175,422
164,405
171,201
190,252
200,201
194,754
194,754200,201190,252171,201164,405175,422152,9970000
       Property Plant Equipment 
132,627
155,399
150,939
137,873
122,168
109,396
95,192
106,247
127,423
138,779
86,584
86,584138,779127,423106,24795,192109,396122,168137,873150,939155,399132,627
       Intangible Assets 
30,350
29,696
29,108
28,423
27,647
60,010
58,525
57,166
55,700
54,002
35,950
35,95054,00255,70057,16658,52560,01027,64728,42329,10829,69630,350
       Long-term Assets Other 
0
0
0
0
152,997
175,422
164,405
171,201
0
0
1,568
1,56800171,201164,405175,422152,9970000
> Total Liabilities 
133,128
94,136
88,159
110,258
79,478
149,336
130,383
93,706
107,857
129,888
102,330
102,330129,888107,85793,706130,383149,33679,478110,25888,15994,136133,128
   > Total Current Liabilities 
108,128
94,136
87,922
110,002
79,452
148,747
129,656
92,973
92,114
90,878
77,779
77,77990,87892,11492,973129,656148,74779,452110,00287,92294,136108,128
       Short-term Debt 
0
0
0
0
20,000
50,000
0
0
0
0
0
0000050,00020,0000000
       Short Long Term Debt 
0
0
0
0
20,000
50,000
0
0
0
0
0
0000050,00020,0000000
       Accounts payable 
4,088
59,585
8,374
14,533
13,445
28,294
8,649
8,037
8,030
24,535
9,100
9,10024,5358,0308,0378,64928,29413,44514,5338,37459,5854,088
       Other Current Liabilities 
99,040
9,552
29,548
45,469
30,849
36,288
52,308
43,652
49,614
26,921
19,675
19,67526,92149,61443,65252,30836,28830,84945,46929,5489,55299,040
   > Long-term Liabilities 
0
0
0
0
26
589
727
733
15,742
39,011
24,551
24,55139,01115,742733727589260000
       Other Liabilities 
0
0
0
256
26
589
727
733
723
589
0
058972373372758926256000
       Deferred Long Term Liability 
0
0
0
1,187
1,494
1,022
551
217
25
0
0
00252175511,0221,4941,187000
> Total Stockholder Equity
165,452
257,484
270,517
241,310
211,975
463,427
464,128
467,623
470,855
418,858
401,156
401,156418,858470,855467,623464,128463,427211,975241,310270,517257,484165,452
   Common Stock
50,000
50,000
50,000
75,000
75,000
100,000
130,000
169,000
219,700
219,700
0
0219,700219,700169,000130,000100,00075,00075,00050,00050,00050,000
   Retained Earnings 
113,249
205,281
218,313
166,310
136,975
125,928
126,628
130,124
133,355
81,359
30,988
30,98881,359133,355130,124126,628125,928136,975166,310218,313205,281113,249
   Capital Surplus 00000000000
   Treasury Stock00000000000
   Other Stockholders Equity 00000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue105,162
Cost of Revenue-52,110
Gross Profit53,05253,052
 
Operating Income (+$)
Gross Profit53,052
Operating Expense-128,042
Operating Income-22,881-74,991
 
Operating Expense (+$)
Research Development797
Selling General Administrative57,552
Selling And Marketing Expenses-
Operating Expense128,04258,349
 
Net Interest Income (+$)
Interest Income254
Interest Expense-1,934
Other Finance Cost-117
Net Interest Income-1,797
 
Pretax Income (+$)
Operating Income-22,881
Net Interest Income-1,797
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-19,818-22,881
EBIT - interestExpense = -1,934
-21,613
-19,679
Interest Expense1,934
Earnings Before Interest and Taxes (EBIT)--17,883
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-19,818
Tax Provision-1,796
Net Income From Continuing Ops-21,613-21,613
Net Income-21,613
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-1,797
 

Technical Analysis of Dali Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Dali Pharmaceutical Co Ltd. The general trend of Dali Pharmaceutical Co Ltd is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Dali Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Dali Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 15.97 < 17.64 < 18.47.

The bearish price targets are: 6.8 > 5.24.

Tweet this
Dali Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Dali Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Dali Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Dali Pharmaceutical Co Ltd. The current macd is -0.69573248.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Dali Pharmaceutical Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Dali Pharmaceutical Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Dali Pharmaceutical Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Dali Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartDali Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Dali Pharmaceutical Co Ltd. The current adx is 15.43.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Dali Pharmaceutical Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Dali Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Dali Pharmaceutical Co Ltd. The current sar is 6.8.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Dali Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Dali Pharmaceutical Co Ltd. The current rsi is 42.55. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Dali Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartDali Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Dali Pharmaceutical Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Dali Pharmaceutical Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Dali Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartDali Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Dali Pharmaceutical Co Ltd. The current cci is -64.30847674.

Dali Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartDali Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Dali Pharmaceutical Co Ltd. The current cmo is -18.88276997.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Dali Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartDali Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Dali Pharmaceutical Co Ltd. The current willr is -71.30242826.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Dali Pharmaceutical Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Dali Pharmaceutical Co Ltd Daily Williams %R ChartDali Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Dali Pharmaceutical Co Ltd.

Dali Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Dali Pharmaceutical Co Ltd. The current atr is 0.92704757.

Dali Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartDali Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Dali Pharmaceutical Co Ltd. The current obv is 450,101,250.

Dali Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartDali Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Dali Pharmaceutical Co Ltd. The current mfi is 64.00.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Dali Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartDali Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Dali Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-19MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-18ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-20ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

Dali Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Dali Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.551
Ma 20Greater thanMa 509.553
Ma 50Greater thanMa 1009.223
Ma 100Greater thanMa 20010.219
OpenGreater thanClose7.880
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Dali Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Dali Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Dali Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Dali Pharmaceutical Co Ltd

I send you an email if I find something interesting about Dali Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Dali Pharmaceutical Co Ltd.

Receive notifications about Dali Pharmaceutical Co Ltd in your mailbox!